Deep Wise

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Deep Wise - overview

Established

2017

Location

Beijing, -, China

Primary Industry

Healthcare

About

Established in 2017 and based in Beijing, China, Deep Wise operates as a medical technology company that provides medical service institutions with internet medical solutions based on artificial intelligence technology. The company’s chairman, Lei Ming, obtained a master’s degree in computer science from Peking University. He is the founder of Kuwo Music and the director of Peking University’s Artificial Intelligence Innovation Center. The company’s CEO, Qiao Xin, graduated from Zhejiang University, majoring in biomedical engineering.


He was the former Vice President of Siemens (China) Medical Business Unit Greater China. The company is headquartered in Beijing and has branches in Shanghai and Hangzhou. In January 2025, it raised venture funding for approximately CNY 500 million. The company's main products include artificial intelligence-assisted diagnosis systems, cloud imaging systems, and scientific research platforms.


The diagnosis system and cloud imaging system mainly provide doctors with clinical diagnosis suggestions and realize the exchange of medical data. They are currently used in early cancer screening and children's growth and development evaluation. The scientific research platform can simplify the complex process of imagingomics scientific research through machine learning technology. It uses a variety of classification models to automatically find the best combination for result analysis.


Deep Wise generates revenue by providing all-inclusive AI - based digital medical services, such as AI - assisted diagnosis and patient service solutions, to numerous medical institutions. The company will use the venture funding to build AI-digitalized healthcare products and solutions.


Current Investors

DHVC, Kinzon Capital, FengHe Fund Management

Primary Industry

Healthcare

Sub Industries

Diagnostic, Medical & Imaging Laboratories, Healthcare IT

Website

www.deepwise.com

Verticals

Artificial Intelligence, HealthTech

Company Stage

Series D

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.